Metachronous colorectal cancer risk in patients with a moderate family history

Colorectal Disease

Volumn 15, Issue 3, 2013, Pages 309-316

  Newton, K F ^a   Green, K ^b   Walsh, S ^b   Lalloo, F ^b   Hill, J ^a   Evans, D G R ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Metachronous colorectal cancer; Moderate familial risk

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; COLORECTAL CANCER; FAMILY HISTORY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; METACHRONOUS COLORECTAL CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEDIGREE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84874374444     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12005     Document Type: Article

References (23)

1. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010; 59: 666-89.
2. Nelson RL, Persky V, Turyk M. Determination of factors responsible for the declining incidence of colorectal cancer. Dis Colon Rectum 1999; 42: 741-52.
3. Soreide K. Endoscopic surveillance after curative surgery for sporadic colorectal cancer: patient-tailored, tumor-targeted or biology-driven?Scand J Gastroenterol 2010; 45: 1255-61.
4. Balleste B, Bessa X, Pinol V et al. Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors. Dis Colon Rectum 2007; 50: 971-80.
5. Kahi CJ, Azzouz F, Juliar BE, Imperiale TF. Survival of elderly persons undergoing colonoscopy: implications for colorectal cancer screening and surveillance. Gastrointest Endosc 2007; 66: 544-50.
6. Pramateftakis MG, Hatzigianni P, Kanellos D et al. Metachronous colorectal cancer. Tech Coloproctol 2010; 14(Suppl. 1): S63-4.
7. Rex DK, Kahi CJ, Levin B et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006; 56: 160-7; quiz 185-166.
8. Curtis RE, Freedman DM, Ron E et al. (eds). (2006) New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute, Bethesda, MD (Chapter 5: New Malignancies following cancer of the colon, rectum and anus, editd by Mysliwiec PA, Cronin KA, Schatzkin A).
9. Kalady MF, McGannon E, Vogel JD, Manilich E, Fazio VW, Church JM. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg 2010; 252: 507-11; discussion 511-503.
10. de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 2002; 45: 1588-94.
11. Natarajan N, Watson P, Silva-Lopez E, Lynch HT. Comparison of extended colectomy and limited resection in patients with Lynch syndrome. Dis Colon Rectum 2010; 53: 77-82.
12. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002; 1: CD002200.
13. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 324: 813.
14. Richard CS, McLeod RS. Follow-up of patients after resection for colorectal cancer: a position paper of the Canadian Society of Surgical Oncology and the Canadian Society of Colon and Rectal Surgeons. Can J Surg 1997; 40: 90-100.
15. Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med 1997; 12: 318-31.
16. Barnetson RA, Tenesa A, Farrington SM et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006; 354: 2751-63.
17. URL: http://publications.nice.org.uk/colorectal-cancer-cg131/guidance#ongoing-care-and-support (accessed May 2012).
18. Barrow E, Jagger E, Brierley J et al. Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome. Histopathology 2011; 56: 331-44.
19. Evans DG, Walsh S, Jeacock J et al. Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer. Br J Surg 1997; 84: 1281-5.
20. URL: http://CRAN.R-project.org/doc/FAQ/R-FAQ.html (accessed October 2011).
21. Coviello V, Boggess M. Cumulative Incidence estimation in the presence of competing risks. Stata J 2004; 4: 103-12.
22. Gray RJ, Fine JP. A class of K sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-54.
23. Parry S, Win AK, Parry B et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 2011; 60: 950-7.